Jesse Dovich, MD, Wins Tesla at 2017 ASCRS Meeting

May 8, 2017: By Market Scope
Jesse Dovich, MD (right), winner of the Tesla at the 2017 ASCRS meeting.

Jesse Dovich, MD (right), winner of the Tesla at the 2017 ASCRS meeting. (Photo by Katie Cannady)

 

Ophthalmologist Jesse Dovich, MD, of Upland, California, was the winner of this year’s drawing for a Tesla electric car at the ASCRS annual meeting in Los Angeles.

The drawing was held May 8 at the ASCRS Exhibit Hall.

Dovich won a 2017 sapphire blue Model S.

He practices at the Pacific Eye Institute and Laser Center, with several locations in California, and is a clinical instructor with the Department of Ophthalmology at Loma Linda University.

In 2015, Thomas Carter, MD, of Ponca City, OK, won the ASCRS’ initial drawing for a 2015 red Tesla Model S at the meeting in San Diego.

In 2016, David Russell Brear, MD, of Culpeper, VA, was the winner of a blue Tesla Model S at the annual meeting in New Orleans.

This year’s drawing was available to conference attendees who obtained specially numbered tickets from exhibitors or ASCRS officials.

Attendees also could gain a ticket by contributing to the ASCRS Foundation or completing the ASCRS clinical survey.

Dovich’s ticket was the first one drawn.

 

A crowd forms May 8 at the Exhibit Hall for the drawing of a Tesla Model S at the 2017 ASCRS meeting in Los Angeles.

A crowd forms May 8 at the Exhibit Hall for the drawing of a Tesla Model S at the 2017 ASCRS meeting in Los Angeles. (Photo by Tony Ingenito)

 

Tesla winner Jesse Dovich after the drawing

Tesla winner Jesse Dovich, MD, after the drawing. (Photo by Katie Cannady)

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

FDA Ophthalmic Devices Panel to hold Meeting Oct. 27

Novartis’ RTH258 Successful in Two Phase III Studies for nAMD

Ocugen Closes $7.5 Million Series B Round

Genentech Uses Vital Art and Science Vision-Testing App in Phase II Study of Sustained Delivery of Lucentis

US Supreme Court Ruling Shortens Time to Market for Biosimilars

Ellex Acquires Royalty Commitment for iTrack Device for $2.15 Million

Johnson & Johnson Vision Names Jonathan Talamo, MD, Chief Medical Officer

Teva Launches Generic Versions of Pataday in US

David Karcher Stepping Down as Executive Director, CEO of ASCRS

EyeGate Raises $10 Million in Public Offering

Aerie Raises $125 Million through Upsized Public Offering, ATM Program

pSivida’s Durasert for Posterior Segment Uveitis Successful in Second Phase III Study

Mynosys Zepto Receives US FDA 510(k) Clearance

Ozurdex, Humira Gain NICE Backing for Non-infectious Posterior Uveitis

Roger Steinert, Pioneer in Ophthalmology, Dies at 66

Carl Zeiss Meditec to Build New Innovation Center in Northern California

Gottlieb Says FDA to Publish List of Drugs Without Generic Competition

REGENXBIO Announces Phase I Clinical Trial for RGX-314 Gene Therapy for Wet AMD

Belkin Laser Closes Nearly $5 Million Financing Round

Valeant in Talks to Sell Surgical Business to Carl Zeiss Meditec

Coming soon

2017 Cataract Surgical Equipment: A Global Market Analysis for 2016 to 2022